About Immunoglobulin heavy constant gamma 2
Immunoglobulin heavy constant gamma 2 (IGHG2) is a protein
from Homo sapiens identified by UniProt accession
P01859, 395 residues long.
MolForge cross-references it against 0 known binders and
155 disease associations.
Target properties
| Protein name | Immunoglobulin heavy constant gamma 2 |
| UniProt accession | P01859 |
| Gene | IGHG2 |
| Organism | Homo sapiens |
| Length | 395 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | LOW |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (155)
Diseases linked to this target (Open Targets).
- cutaneous Leishmaniasis · score 0.59
- recurrent infections associated with rare immunoglobulin isotypes deficiency · score 0.38
- immune deficiency, familial variable · score 0.08
- common variable immunodeficiency · score 0.08
- combined immunodeficiency with skin granulomas · score 0.07
- hyper-IgM syndrome type 3 · score 0.07
- classic Hodgkin lymphoma · score 0.07
- Hodgkins lymphoma · score 0.07
- severe combined immunodeficiency due to CARD11 deficiency · score 0.07
- BENTA disease · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P01859-F1 | alphafold | PREDICTED | 87.36 | — |
Amino-acid sequence (395 residues)
ASTKGPSVFP LAPCSRSTSE STAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS GLYSLSSVVT VPSSNFGTQT YTCNVDHKPS NTKVDKTVER KCCVECPPCP APPVAGPSVF LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVQFNWYVDG VEVHNAKTKP REEQFNSTFR VVSVLTVVHQ DWLNGKEYKC KVSNKGLPAP IEKTISKTKG QPREPQVYTL PPSREEMTKN QVSLTCLVKG FYPSDISVEW ESNGQPENNY KTTPPMLDSD GSFFLYSKLT VDKSRWQQGN VFSCSVMHEA LHNHYTQKSL SLSPELQLEE SCAEAQDGEL DGLWTTITIF ITLFLLSVCY SATITFFKVK WIFSSVVDLK QTIVPDYRNM IRQGA
Explore Immunoglobulin heavy constant gamma 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets